Novel prostate cancer target for diagnosis, imaging, detection of recurrence and response to therapy

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1093539

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This project will generate the critical proof of concept to justify clinical development of a novel biomarker in prostate cancer which would bring significant benefit in terms of differential diagnosis of aggressive disease. The biomarker will be assessed for a functional role in prostate cancer and potential as a therapeutic target and use as a imaging agent in for monitoring disease progression and response to therapy. These investigations will be extended to other common solid tumours.

Funded Activity Details

Start Date: 01-01-2015

End Date: 01-01-2018

Funding Scheme: Development Grants

Funding Amount: $731,497.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Oncology and Carcinogenesis not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cancer cell biology | cancer detection | cancer metastasis | imaging | prostate cancer

Related Links